The Insigh T (NIPT) Plus (Lilac) test is a state-of-the-art prenatal screening tool that offers expectant parents invaluable insights into their baby's genetic health. This non-invasive test analyzes the fetal DNA circulating in the mother's bloodstream to detect any chromosomal abnormalities or genetic conditions.
The lilac test, also known as Insigh T (NIPT) Plus (Lilac), is a non-invasive prenatal screening test that analyzes fetal DNA present in the mother's blood. This advanced screening technology can provide valuable insights into the genetic health of the unborn baby.
One key difference between Nifty and NIPT lies in the technology used. Nifty utilizes next-generation sequencing (NGS) technology to analyze cell-free DNA from the mother's blood sample.
On the other hand, NIPT is a broader term that encompasses various brands and methods of non-invasive prenatal testing. While Nifty is one specific brand within this category, there are other commercially available NIPT options as well.
When the results of the NIPT test come back positive, it means that there is an increased likelihood of a chromosomal abnormality in the fetus.
It's important to note that medical recommendations regarding the use of NIPT may vary from country to country and even between healthcare providers within the same country. In some cases, NIPT may be recommended for women who are at higher risk of having a baby with chromosomal abnormalities based on their age or other factors. In other cases, it may be offered as an option but not required.
Yes, the NIPT test is legal in India. In fact, it has gained popularity among expectant parents who want to ensure a healthy pregnancy and make informed decisions about their baby's health.